Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Cohort)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by Centre Hospitalier Universitaire Dijon
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT01766596
First received: January 10, 2013
Last updated: NA
Last verified: January 2013
History: No changes posted

January 10, 2013
January 10, 2013
October 2009
October 2013   (final data collection date for primary outcome measure)
Measure the mean thickness of postganglionic fibers [ Time Frame: T=7 years of the 3C cohort ]
Measure the thickness of postganglionic fibers by Optical Coherence Tomography in the 4 quadrants of the peripapillary sclera.
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Cohort)
Study the Signs of Ocular Degeneration in a Population Cohort (Dijon 3C Cohort): Seek Correlations Between Signs of Neurological and Vascular Degeneration and Signs of Ocular Aging

The aim of the study proposed in Dijon is above all to focus on the possible relationship between age-related ocular pathologies (AMD and glaucoma) and et les degenerative neurological and cardiac pathologies.

The principal objective is to seek in subjects who have undergone cerebral MRI and echocardiography, associations between the thickness of postganglionic fibers measured by Optical Coherence Tomography at the 7th year (n=1500) and signs of cerebral impairment (psycho-cognitive tests, circulation time, MRI signs). This association will be studied after taking into account the principal environmental (particularly dietary) and genetic risk factors.

Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
  • AMD
  • Glaucoma
Procedure: Optical Coherence Tomography
3C cohort
Intervention: Procedure: Optical Coherence Tomography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
3000
Not Provided
October 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Persons who have given their written consent
  • Persons who are taking part in the Dijon 3C study

Exclusion Criteria:

  • Persons who are not registered with social security agency
  • Persons who are unable to sit upright during a consultation
Both
Not Provided
No
Contact: Catherine CREUZOT-GARCHER 3 80 29 51 73 ext 33 catherine.creuzot-garcher@chu-dijon.fr
France
 
NCT01766596
Creuzot-Garcher PHRC IR 2009
Not Provided
Centre Hospitalier Universitaire Dijon
Centre Hospitalier Universitaire Dijon
Not Provided
Not Provided
Centre Hospitalier Universitaire Dijon
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP